Characterization of Transgenic Mouse Models of Alzheimer's Disease and Related Dementia
- Weitere Titel
-
Charakterisierung von transgenen Mausmodellen der Alzheimer'schen Demenz und verwandter Demenzen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2021
- Ereignis
-
Veröffentlichung
- (wo)
-
Düsseldorf
- (wer)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
-
Langen, Karl-Josef
- URN
-
urn:nbn:de:hbz:061-20211028-111506-6
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Camargo, Luana Cristina
- Langen, Karl-Josef
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Entstanden
- 2021
Ähnliche Objekte (12)
Modulation of Alzheimer's pathology in transgenic mouse models
C-terminally truncated Amyloid-β peptides in Alzheimer’s dementia: Deposition of Aβ37, Aβ38, and Aβ39 in the brains of patients with sporadic and familiar Alzheimer’s dementia and in transgenic mouse models.
Neuropathological and behavioral alterations in two transgenic mouse models of Alzheimer´s disease
Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease
Protective effects of intranasal Iosartan in the APP-PS1 transgenic mouse model of Alzheimer's disease
NVP-BEZ235 (dactolisib) has protective effects in a transgenic mouse model of Alzheimer's disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
Prevention and treatment: Effects on pathological alterations in transgenic Alzheimer’s disease mouse models
Molecular studies on the pathology of Alzheimer's disease with particular emphasis on transgenic mouse models
Influence of acetylcholine esterase inhibitors and memantine, clinically approved for Alzheimer’s dementia treatment, on intestinal properties of the mouse
β-amyloid, cholinergic transmission, and cerebrovascular system - a developmental study in a transgenic mouse model of Alzheimer’s disease
Etiogenesis of Alzeimer's disease in transgenic mouse models
Modulation of Alzheimer's pathology in transgenic mouse models
C-terminally truncated Amyloid-β peptides in Alzheimer’s dementia: Deposition of Aβ37, Aβ38, and Aβ39 in the brains of patients with sporadic and familiar Alzheimer’s dementia and in transgenic mouse models.
Neuropathological and behavioral alterations in two transgenic mouse models of Alzheimer´s disease
Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease
Protective effects of intranasal Iosartan in the APP-PS1 transgenic mouse model of Alzheimer's disease
NVP-BEZ235 (dactolisib) has protective effects in a transgenic mouse model of Alzheimer's disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
Prevention and treatment: Effects on pathological alterations in transgenic Alzheimer’s disease mouse models
Molecular studies on the pathology of Alzheimer's disease with particular emphasis on transgenic mouse models
Influence of acetylcholine esterase inhibitors and memantine, clinically approved for Alzheimer’s dementia treatment, on intestinal properties of the mouse
β-amyloid, cholinergic transmission, and cerebrovascular system - a developmental study in a transgenic mouse model of Alzheimer’s disease
Etiogenesis of Alzeimer's disease in transgenic mouse models
Modulation of Alzheimer's pathology in transgenic mouse models
C-terminally truncated Amyloid-β peptides in Alzheimer’s dementia: Deposition of Aβ37, Aβ38, and Aβ39 in the brains of patients with sporadic and familiar Alzheimer’s dementia and in transgenic mouse models.
Neuropathological and behavioral alterations in two transgenic mouse models of Alzheimer´s disease
Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease
Protective effects of intranasal Iosartan in the APP-PS1 transgenic mouse model of Alzheimer's disease
NVP-BEZ235 (dactolisib) has protective effects in a transgenic mouse model of Alzheimer's disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
Prevention and treatment: Effects on pathological alterations in transgenic Alzheimer’s disease mouse models
Molecular studies on the pathology of Alzheimer's disease with particular emphasis on transgenic mouse models
Influence of acetylcholine esterase inhibitors and memantine, clinically approved for Alzheimer’s dementia treatment, on intestinal properties of the mouse
β-amyloid, cholinergic transmission, and cerebrovascular system - a developmental study in a transgenic mouse model of Alzheimer’s disease